Neuronetics (STIM) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Neuronetics Reports Third Quarter 2023 Financial and Operating Results
November 7, 2023 7:30 AM ESTMALVERN, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the Company or Neuronetics) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced its financial and operating results for the third quarter of 2023.
Third Quarter 2023 Highlights
Third quarter 2023 revenue of $17.9 million, an increase of 8% over the third quarter of 2022Record U.S. treatment session revenue of $13.1 millionShipped 43 NeuroStar systemsRecent... More
